communicable Diseases

antibiotic resistent organisms (ARO)

Antibiotic-Resistant Organisms (AROs)

Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs) In All Health Care Settings

Carbapenemase Producing Enterobacteriaceae (CPE)

Clostridioides difficile Infections (CDI)

Methicillin Resistant Staphylococcus aureus (MRSA)

Vancomycin resistant enterococci (VRE)

Fact Sheet - Clostridium difficile (C. difficile)

Fact Sheet - Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA)

Fact Sheet - Vancomycin-resistant Enterococci (VRE)

emerging diseases

Carbapenemase Producing Enterobacteriaceae (CPE)

Mpox (formerly known as monkeypox)

Emerging and Re-Emerging Diseases

Emerging Diseases

gastrointestinal illness

Appendix 1: Case Definitions and Disease-Specific Information Disease: Gastroenteritis Outbreaks in Institutions and Public Hospitals

Recommendations for Outbreak Prevention and Control in Institutions and Congregate Living Settings

Enteric Diseases and Food-Borne Diseases

infectious diseases

Reportable Diseases of Public Health Significance

Infectious Diseases

Diseases and Conditions Index

Clinical Syndromes/Conditions with Required Level or Precautions

Infectious Diseases

respiratory illness

Appendix 1: Case Definitions and Disease Specific Information: Respiratory Infection Outbreaks in Institutions and Public Hospitals

COVID-19 Guidance for Public Health Units: Long-Term Care Homes, Retirement Homes, and Other Congregate Living Settings

Recommendations for Outbreak Prevention and Control in Institutions and Congregate Living Settings

Respiratory Diseases

Coronavirus Disease 2019 (COVID-19)

Influenza (flu)

Cohorting in Respiratory Virus Outbreaks

Public Health Ontario Ontario Respiratory Virus Tool

Subscribe to our mailing list

Page updated

Report abuse